Vyro is selected by Anvisa for regulatory monitoring
We are honored to announce that Vyro Bio has been selected by Anvisa to participate in the regulatory guidance program aimed at innovative startups in the development of medications. This [...]
More
Vyro is featured in Folha de São Paulo
Last Wednesday (29), Vyro was featured in Folha de São [...]
#TBT: BioLatam Brazil 2024
On today's #tbt, let's reminisce about Dra. Carolini Kaid's participation [...]
Open Conference (MCTI) – An integrated model between government, industry and academia
Today, let's remember Dra. Carolini Kaid's (@carolini_kaid) participation in the [...]
